TRAVERSA SERGIO (Chief Executive Officer) purchased 2.2% of their position (27.50K shares) of RELMADA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $113.3K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/16/2025ACC: 0001213900-25-121974
DirectorOfficer· Chief Executive Officer
Since Dec 2018
+1.23M
Net shares
Net buyer
$113.3K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
1.23M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+27.50K
Price / share
$4.12
Trade value
$113.30K
% of position
2.2%
12/15/2025
1.27M→1.30M
Total
Net shares
+27.50K
Net value
$113.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/15/2025 | P · Purchase | +27.50K | $4.12 | $113.30K | 2.2% | 1.27M | 1.30M |
| Total | +27.50K | $113.30K | ||||||
Derivative Transactions1
Stock Appreciation Rights
Direct
Converts to
Common Stock
1.20M shares
Shares
+1.20M
Strike price
4.06
Held after
1.20M
Exercisable
—
12/12/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Appreciation Rights Direct | Common Stock1.20M shares | 12/12/2025 | A · Award | +1.20M | 4.06 | — | 1.20M |